Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

BACKGROUND: Anti-epidermal growth factor receptor treatment strategies, i.e. monoclonal antibodies such as cetuximab and panitumumab, or epidermal growth factor receptor (EGFR) small molecule tyrosine kinase inhibitors, such as erlotinib and gefitinib, have expanded the treatment options for differe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Potthoff, Karin (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn) , Hassel, Jessica C. (VerfasserIn) , Volkenandt, M. (VerfasserIn) , Lordick, F. (VerfasserIn) , Hartmann, J. T. (VerfasserIn) , Karthaus, M. (VerfasserIn) , Riess, H. (VerfasserIn) , Lipp, H. P. (VerfasserIn) , Hauschild, A. (VerfasserIn) , Trarbach, T. (VerfasserIn) , Wollenberg, A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2011
In: Annals of oncology
Year: 2011, Jahrgang: 22, Heft: 3, Pages: 524-535
ISSN:1569-8041
DOI:10.1093/annonc/mdq387
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/annonc/mdq387
Volltext
Verfasserangaben:K. Potthoff, R. Hofheinz, J.C. Hassel, M. Volkenandt, F. Lordick, J.T. Hartmann, M. Karthaus, H. Riess, H.P. Lipp, A. Hauschild, T. Trarbach, A. Wollenberg

MARC

LEADER 00000caa a2200000 c 4500
001 1831065835
003 DE-627
005 20230710095118.0
007 cr uuu---uuuuu
008 230113s2011 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdq387  |2 doi 
035 |a (DE-627)1831065835 
035 |a (DE-599)KXP1831065835 
035 |a (OCoLC)1389738414 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Potthoff, Karin  |d 1969-  |e VerfasserIn  |0 (DE-588)121719499  |0 (DE-627)081489242  |0 (DE-576)292848013  |4 aut 
245 1 0 |a Interdisciplinary management of EGFR-inhibitor-induced skin reactions  |b a German expert opinion  |c K. Potthoff, R. Hofheinz, J.C. Hassel, M. Volkenandt, F. Lordick, J.T. Hartmann, M. Karthaus, H. Riess, H.P. Lipp, A. Hauschild, T. Trarbach, A. Wollenberg 
264 1 |c 2011 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 6 January 2020 
500 |a Gesehen am 13.01.2023 
520 |a BACKGROUND: Anti-epidermal growth factor receptor treatment strategies, i.e. monoclonal antibodies such as cetuximab and panitumumab, or epidermal growth factor receptor (EGFR) small molecule tyrosine kinase inhibitors, such as erlotinib and gefitinib, have expanded the treatment options for different tumor types. Dermatologic toxic effects are the most common side-effects of EGFR inhibitor therapy. They can profoundly affect the patient's quality of life. - PURPOSE: The aim of this study was to provide interdisciplinary expert recommendations on how to treat patients with skin reactions undergoing anti-EGFR treatment. - MATERIAL AND METHODS: An expert panel from Germany with expertise in medical oncology, dermatology or clinical pharmacology was convened to develop expert recommendations based on published peer-reviewed literature. - RESULTS: The expert recommendations for the state-of-the-art treatment of skin reactions induced by EGFR inhibitor therapy include recommendations for diagnostics and grading as well as grade-specific and stage-adapted treatment approaches and preventive measures. It was concluded that EGFR-inhibitor-related dermatologic reactions should always be treated combining basic care of the skin and a specific therapy adapted to stage and grade of skin reaction. For grade 2 and above, specific treatment recommendations for early- and later-stage skin reactions induced by EGFR-inhibitor therapy were proposed. - CONCLUSION: This paper presents a German national expert opinion for the treatment of skin reactions in patients receiving EGFR inhibitor therapy. 
650 4 |a Acneiform Eruptions 
650 4 |a Antibodies, Monoclonal 
650 4 |a Antibodies, Monoclonal, Humanized 
650 4 |a Cetuximab 
650 4 |a Disease Management 
650 4 |a ErbB Receptors 
650 4 |a Germany 
650 4 |a Humans 
650 4 |a Panitumumab 
650 4 |a Vitamin K 3 
700 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
700 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
700 1 |a Volkenandt, M.  |e VerfasserIn  |4 aut 
700 1 |a Lordick, F.  |e VerfasserIn  |4 aut 
700 1 |a Hartmann, J. T.  |e VerfasserIn  |4 aut 
700 1 |a Karthaus, M.  |e VerfasserIn  |4 aut 
700 1 |a Riess, H.  |e VerfasserIn  |4 aut 
700 1 |a Lipp, H. P.  |e VerfasserIn  |4 aut 
700 1 |a Hauschild, A.  |e VerfasserIn  |4 aut 
700 1 |a Trarbach, T.  |e VerfasserIn  |4 aut 
700 1 |a Wollenberg, A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 22(2011), 3, Seite 524-535  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Interdisciplinary management of EGFR-inhibitor-induced skin reactions a German expert opinion 
773 1 8 |g volume:22  |g year:2011  |g number:3  |g pages:524-535  |g extent:12  |a Interdisciplinary management of EGFR-inhibitor-induced skin reactions a German expert opinion 
856 4 0 |u https://doi.org/10.1093/annonc/mdq387  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230113 
993 |a Article 
994 |a 2011 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 3 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 61200  |e 60000PH121917517  |e 61200PH121917517  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 121719499  |a Potthoff, Karin  |m 121719499:Potthoff, Karin  |d 910000  |d 911400  |e 910000PP121719499  |e 911400PP121719499  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1831065835  |e 4247854593 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"subtitle":"a German expert opinion","title":"Interdisciplinary management of EGFR-inhibitor-induced skin reactions","title_sort":"Interdisciplinary management of EGFR-inhibitor-induced skin reactions"}],"relHost":[{"pubHistory":["1.1990 -"],"part":{"text":"22(2011), 3, Seite 524-535","year":"2011","volume":"22","issue":"3","pages":"524-535","extent":"12"},"language":["eng"],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"320428796","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990","dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press"}],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"disp":"Interdisciplinary management of EGFR-inhibitor-induced skin reactions a German expert opinionAnnals of oncology","id":{"eki":["320428796"],"zdb":["2003498-2"],"issn":["1569-8041"]},"physDesc":[{"extent":"Online-Ressource"}]}],"note":["Available online 6 January 2020","Gesehen am 13.01.2023"],"id":{"doi":["10.1093/annonc/mdq387"],"eki":["1831065835"]},"physDesc":[{"extent":"12 S."}],"recId":"1831065835","origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"family":"Potthoff","given":"Karin","role":"aut","display":"Potthoff, Karin"},{"family":"Hofheinz","given":"Ralf-Dieter","role":"aut","display":"Hofheinz, Ralf-Dieter"},{"role":"aut","given":"Jessica C.","display":"Hassel, Jessica C.","family":"Hassel"},{"display":"Volkenandt, M.","role":"aut","given":"M.","family":"Volkenandt"},{"role":"aut","given":"F.","display":"Lordick, F.","family":"Lordick"},{"family":"Hartmann","display":"Hartmann, J. T.","given":"J. T.","role":"aut"},{"family":"Karthaus","display":"Karthaus, M.","role":"aut","given":"M."},{"given":"H.","role":"aut","display":"Riess, H.","family":"Riess"},{"display":"Lipp, H. P.","given":"H. P.","role":"aut","family":"Lipp"},{"family":"Hauschild","display":"Hauschild, A.","given":"A.","role":"aut"},{"role":"aut","given":"T.","display":"Trarbach, T.","family":"Trarbach"},{"family":"Wollenberg","role":"aut","given":"A.","display":"Wollenberg, A."}],"name":{"displayForm":["K. Potthoff, R. Hofheinz, J.C. Hassel, M. Volkenandt, F. Lordick, J.T. Hartmann, M. Karthaus, H. Riess, H.P. Lipp, A. Hauschild, T. Trarbach, A. Wollenberg"]}} 
SRT |a POTTHOFFKAINTERDISCI2011